Chariot (LON: CHAR) is supporting Etu Energias in its acquisition of Chevron’s 31% operated interest in Block 14 and 15.5% of Block 14K, offshore Angola. This provides exposure to 4,000 barrels of oil equivalent per day. At $70/barrel for Chariot’s total net production, Cavendish has updated the target share price to 8.3p. Malcolm MacLean has a 5.36% interest. The share price jumped 61.8% to 2.75p.
Kazera Global (LON: KZG) subsidiary Whale Head Minerals has been granted a mining right over sea concession 2A in South Africa. This triggers a $1.75m from partner South Africa AT Investments, which will extend operations to 2A. It is expected to announce an overall mine plan in the next few weeks. Plant is due to arrive in November. Commercial production is expected in the first quarter of 2027. A settlement has been reached with Fujax under prepayment arrangements. The total payable is $1m in shares and cash over five monthly payments. A fundraising is expected to generate at least £500,000. The share price gained 22.2% to 0.825p before it was suspended due to the proposed fundraising.
Medpal AI (LON: MPAL) has completed the acquisition of eMARx and thfinal payment is 1.08 million shares. FDA approval of Mounjaro for heart protection will expand the GLP-1 market. In the UK there is a potential market of 1.4 million people. However, there is no news that this will be allowed in the UK. Medpal AI says its subsidiary New Health is offering Foundayo, which gained UK approval in August. The share price rose 19.5% to 5.2p.
Rent guarantees provider RentGuarantor (LON: RGG) has released another positive trading statement leading to a further forecast upgrade. Revenues in the eight months to August 2026 were 472% higher at £8.45m. That includes £3.17m generated in August. The average contract level has increased. Cash was £7.5m at the end of August 2026 and the commencement of dividends is possible. Management targets a full year pre-tax profit of £4m and that could double next year. The share price increased 19.2% to 93p and it is 238% higher so far this year.
FALLERS
LiDAR wind sensors developer Windar Photonics (LON: WPHO) shares returned from suspension down 77.7% to 5.92p. This follows the oversubscribed retail offer that raised £245,000 at 5p/share, taking the total fundraising to £5.12m. The exercise price of the warrants held by GEM has been reduced. The audit of the 2025 accounts was finally completed at the end of August. The delay was due to accounting irregularities, which led to changes in revenue recognition
Foreign exchange services provider Finseta (LON: FIN) says that first half revenues fell from £5.9m to £5.4m. It puts the blame on the conflict in the Middle East. Although Middle East revenues have risen, Finseta has been putting in place a cost base assuming much higher revenues. The poor economic climate has also hit income. Net cash was £400,000 at the end of June 2026. Second half revenues are expected to be similar to the first half and a 2026 loss of £2.6m is forecast. The share price slumped 34.9% to 7p.
Premier African Minerals (LON: PREM) has sent a circular for a general meeting to gain shareholder approval for management to issue shares and disapply pre-emption rights. Management forecasts a requirement for $19.1m up until the end of 2027. The general meeting would provide the ability to raise around $12.7m at a share price of 0.016p. This would not be raised in one go. There will also be a ten-for-one share consolidation. The share price slid 32.6% to 0.0091p.
Futura Medical (LON: FUM) has raised £1.6m at 0.2p/share and launched a formal sales process. A retail offer could raise up to £150,000 more. This should provide enough cash to get to February 2027 giving the company time to assess approaches for the business and/or assets. The board believes that the company is undervalued. WSD4000, which is a gel designed to treat impaired sexual response in women, has strong potential. Male erectile dysfunction product Eroxon is showing signs of improved sales. The share price declined 26.8% to 0.278p.